Indeed, a recent CRISPR-meditated approach to cystic fibrosis therapy approach was based on transient application of a modified CRISPR system to edit the gene encoding cystic fibrosis transmembrane conductance regulator [28]. The gene discussed is CFTR; the disease is cystic fibrosis.